Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Obesity is now understood as a condition that affects the functions of organs and tissues, leading to complications such as ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...